Position in XENE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,868,504
+$68,413 QoQ
Shares Held
30,956
0.0% QoQ
Ownership
0.032%
of shares outstanding
% of Portfolio
6.85%
of 13F equity value
Holder Rank
#148
of 309 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in XENE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026TLS Advisors LLC holds $1,919,232 across 4 Biotechnology names. XENE ranks #1 (97.4% of the industry book) .
All Filings in XENE
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,868,504 | 30,956 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,800,091 | 30,956 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $307 | 18,858 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $1,323,183 | 32,956 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $1,031,522 | 32,956 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $1,105,673 | 32,956 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $1,291,875 | 32,956 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,297,477 | 32,956 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,284,954 | 32,956 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $1,418,755 | 32,956 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $1,517,953 | 32,956 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,125,776 | 32,956 | Shares | Sole | 2023-11-16 | |
| 2023-06-30 | $1,299,606 | 33,756 | Shares | Sole | 2023-11-16 | |
| 2023-03-31 | $1,208,127 | 33,756 | Shares | Sole | 2023-11-16 | |
| 2022-12-31 | $1,330,999 | 33,756 | Shares | Sole | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||